Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells

Abdul, 2009, Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling, J. Neurosci., 29, 12957, 10.1523/JNEUROSCI.1064-09.2009 Abe, 2003, Amyloid beta protein enhances the clearance of extracellular L-glutamate by cultured rat cortical astrocytes, Neurosci. Res., 45, 25, 10.1016/S0168-0102(02)00190-6 Al, 2016, Neuronal activity mediated regulation of glutamate transporter GLT-1 surface diffusion in rat astrocytes in dissociated and slice cultures, Glia, 64, 1252, 10.1002/glia.22997 Anderson, 2000, Astrocyte glutamate transport: review of properties, regulation, and physiological functions, Glia, 32, 1, 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W Benilova, 2012, The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes, Nat. Neurosci., 15, 349, 10.1038/nn.3028 Bitan, 2003, Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways, Proc. Natl. Acad. Sci. U. S. A., 100, 330, 10.1073/pnas.222681699 Boycott, 2008, Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters, Glia, 56, 998, 10.1002/glia.20673 Chen, 2002, Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain, J. Neurosci., 22, 2142, 10.1523/JNEUROSCI.22-06-02142.2002 Chen, 2004, The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons, J. Neurosci., 24, 1136, 10.1523/JNEUROSCI.1586-03.2004 Danbolt, 2001, Glutamate uptake, Prog. Neurobiol., 65, 1, 10.1016/S0301-0082(00)00067-8 Furness, 2008, A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2), Neuroscience, 157, 80, 10.1016/j.neuroscience.2008.08.043 Garcia-Tardon, 2012, Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2-dependent ubiquitination but not phosphorylation, J. Biol. Chem., 287, 19177, 10.1074/jbc.M112.355909 Gegelashvili, 1997, Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia, J. Neurochem., 69, 2612, 10.1046/j.1471-4159.1997.69062612.x Gerakis, 2016, Abeta42 oligomers modulate beta-secretase through an XBP-1s-dependent pathway involving HRD1, Sci. Rep., 6, 37436, 10.1038/srep37436 Gonzalez-Gonzalez, 2008, PKC-dependent endocytosis of the GLT1 glutamate transporter depends on ubiquitylation of lysines located in a C-terminal cluster, Glia, 56, 963, 10.1002/glia.20670 Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 Han, 2016, Insulin attenuates beta-amyloid-associated insulin/Akt/EAAT signaling perturbations in human astrocytes, Cell. Mol. Neurobiol., 36, 851, 10.1007/s10571-015-0268-5 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Haugeto, 1996, Brain glutamate transporter proteins form homomultimers, J. Biol. Chem., 271, 27715, 10.1074/jbc.271.44.27715 Heneka, 2013, NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice, Nature, 493, 674, 10.1038/nature11729 Heneka, 2015, Innate immunity in Alzheimer's disease, Nat. Immunol., 16, 229, 10.1038/ni.3102 Holmes, 2009, Systemic inflammation and disease progression in Alzheimer disease, Neurology, 73, 768, 10.1212/WNL.0b013e3181b6bb95 Hynd, 2004, Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease, Neurochem. Int., 45, 583, 10.1016/j.neuint.2004.03.007 In, 2001, Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease, N. Engl. J. Med., 345, 1515, 10.1056/NEJMoa010178 Ising, 2015, Current thinking on the mechanistic basis of Alzheimer's and implications for drug development, Clin. Pharmacol. Ther., 98, 469, 10.1002/cpt.200 Jacob, 2007, Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease, J. Alzheimers Dis., 11, 97, 10.3233/JAD-2007-11113 Jin, 2011, Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration, Proc. Natl. Acad. Sci. U. S. A., 108, 5819, 10.1073/pnas.1017033108 Karki, 2014, Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes, Glia, 62, 1270, 10.1002/glia.22679 Kayed, 2013, Molecular mechanisms of amyloid oligomers toxicity, J. Alzheimers Dis., 33, S67 Klein, 2004, Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease, Neurobiol. Aging, 25, 569, 10.1016/j.neurobiolaging.2004.02.010 Klein, 2002, Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int., 41, 345, 10.1016/S0197-0186(02)00050-5 Koffie, 2009, Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques, Proc. Natl. Acad. Sci. U. S. A., 106, 4012, 10.1073/pnas.0811698106 Kuperstein, 2010, Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio, EMBO J., 29, 3408, 10.1038/emboj.2010.211 Lacor, 2007, Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease, J. Neurosci., 27, 796, 10.1523/JNEUROSCI.3501-06.2007 Lauderback, 2001, The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42, J. Neurochem., 78, 413, 10.1046/j.1471-4159.2001.00451.x Lehre, 1998, The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain, J. Neurosci., 18, 8751, 10.1523/JNEUROSCI.18-21-08751.1998 Li, 1997, Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression, J. Neuropathol. Exp. Neurol., 56, 901, 10.1097/00005072-199708000-00008 Li, 2009, Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 Li, 2011, Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors, J. Neurosci., 31, 6627, 10.1523/JNEUROSCI.0203-11.2011 Liu, 2014, IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer's disease, Neurobiol. Aging, 35, 309, 10.1016/j.neurobiolaging.2013.08.016 Liu, 2016, Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer's disease, Front. Pharmacol., 7, 261, 10.3389/fphar.2016.00261 Martinez-Villarreal, 2012, Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination/deubiquitination, Glia, 60, 1356, 10.1002/glia.22354 Martins, 2008, Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice, EMBO J., 27, 224, 10.1038/sj.emboj.7601953 Masliah, 2000, Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice, Exp. Neurol., 163, 381, 10.1006/exnr.2000.7386 Matos, 2008, Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades, Neuroscience, 156, 898, 10.1016/j.neuroscience.2008.08.022 Mattson, 2003, Neuronal and glial calcium signaling in Alzheimer's disease, Cell Calcium, 34, 385, 10.1016/S0143-4160(03)00128-3 Munir, 2000, Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity, Neurochem. Int., 37, 147, 10.1016/S0197-0186(00)00018-8 Murphy-Royal, 2015, Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission, Nat. Neurosci., 18, 219, 10.1038/nn.3901 Palop, 2010, Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks, Nat. Neurosci., 13, 812, 10.1038/nn.2583 Petr, 2015, Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes, J. Neurosci., 35, 5187, 10.1523/JNEUROSCI.4255-14.2015 Raichle, 2002, Appraising the brain's energy budget, Proc. Natl. Acad. Sci. U. S. A., 99, 10237, 10.1073/pnas.172399499 Rong, 2016, TM4 of the glutamate transporter GLT-1 experiences substrate-induced motion during the transport cycle, Sci. Rep., 6, 34522, 10.1038/srep34522 Ronnback, 2004, On the potential role of glutamate transport in mental fatigue, J. Neuroinflammation, 1, 22, 10.1186/1742-2094-1-22 Sastre, 2003, Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase, J. Neurosci., 23, 9796, 10.1523/JNEUROSCI.23-30-09796.2003 Schlag, 1998, Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons, Mol. Pharmacol., 53, 355, 10.1124/mol.53.3.355 Scimemi, 2013, Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1, J. Neurosci., 33, 5312, 10.1523/JNEUROSCI.5274-12.2013 Scott, 2002, Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease, J. Neurosci., 22, C206, 10.1523/JNEUROSCI.22-03-j0004.2002 Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 Sheldon, 2008, Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1, Neurochem. Int., 53, 296, 10.1016/j.neuint.2008.07.010 Sitcheran, 2005, Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression, EMBO J., 24, 510, 10.1038/sj.emboj.7600555 Sultana, 2008, Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide, Mol. Biosyst., 4, 36, 10.1039/B715278G Tanaka, 1997, Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1, Science, 276, 1699, 10.1126/science.276.5319.1699 Thai, 2002, Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease, Brain Pathol., 12, 405 Ullensvang, 1997, Differential developmental expression of the two rat brain glutamate transporter proteins GLAST and GLT, Eur. J. Neurosci., 9, 1646, 10.1111/j.1460-9568.1997.tb01522.x Weggen, 2001, A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity, Nature, 414, 212, 10.1038/35102591 Weng, 2006, Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation, Neuroscience, 138, 1351, 10.1016/j.neuroscience.2005.11.061 Woltjer, 2010, Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease, J. Neuropathol. Exp. Neurol., 69, 667, 10.1097/NEN.0b013e3181e24adb Yan, 2006, Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity, J. Mol. Biol., 364, 853, 10.1016/j.jmb.2006.09.046 Yan, 2014, Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C, Glia, 62, 1093, 10.1002/glia.22665 Yang, 2009, Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1, Neuron, 61, 880, 10.1016/j.neuron.2009.02.010 Zhang, 2015, Ceftriaxone protects astrocytes from MPP(+) via suppression of NF-kappaB/JNK/c-Jun signaling, Mol. Neurobiol., 52, 78, 10.1007/s12035-014-8845-z Zhang, 2016, The GABAA receptor agonist muscimol induces an age-and region-dependent form of long-term depression in the mouse striatum, Learn. Mem., 23, 479, 10.1101/lm.043190.116 Zumkehr, 2015, Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease, Neurobiol. Aging, 36, 2260, 10.1016/j.neurobiolaging.2015.04.005